Skip to content

Guided Imagery in Perimenopausal Women

The Effect of Guided Imagery on Quality of Life and Insomnia in Perimenopausal Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07176611
Enrollment
68
Registered
2025-09-16
Start date
2025-09-15
Completion date
2025-11-30
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perimenopausal Women

Brief summary

The study will be conducted in two groups as guided imagery and control. Participants will be approached at the Public Education Center. After perimenopausal women are evaluated according to eligibility criteria, those who are eligible will be informed about the research and written informed consent will be obtained from those who agree. Random assignment of women to the study groups will be carried out using randomization.

Interventions

OTHERGuided imagery

Participants in this group will receive the guided imagery intervention. The guided imagery audio recording will be applied in a quiet room once during the initial session, and participants will be instructed to continue the practice at home before sleep for eight weeks.

Sponsors

Menekşe Nazlı AKER
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
45 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Being between 45-59 years of age * Being in the perimenopausal period according to the Stages of Reproductive Aging Workshop (STRAW) criteria (stage +1 or +2) * Early menopausal transition (STRAW -2): menstrual cycle length varies by 7 days or more * Late menopausal transition (STRAW -1): amenorrhea lasting 60 days or longer * Having entered natural menopause in postmenopausal women * Scoring above 10 on the Women's Health Initiative Insomnia Rating Scale * Owning a smartphone * Ability to understand and speak Turkish * No hearing impairment * Volunteering to participate in the study

Exclusion criteria

* Having received or currently receiving hormone replacement therapy * Alcohol use * Practicing another mind-body intervention * Having a diagnosed disease that may cause sleep disorders and receiving medical treatment * Having a diagnosed disease that may significantly affect quality of life and receiving medical treatment

Design outcomes

Primary

MeasureTime frameDescription
Change in Quality of Lifeat the beginning of the study, 4 weeks and 8 weeks laterThe Menopause-Specific Quality of Life Questionnaire-II (MENQOL-II) is a 29-item Likert-type scale used to assess the presence and severity of menopausal symptoms in women aged 45-59, including premenopausal, perimenopausal, postmenopausal, and surgical menopause. The scale has four subdomains: vasomotor, psychosocial, physical, and sexual. Each item is scored from 1 to 8, yielding a total score range between 29 and 232. Higher scores indicate a greater negative impact of menopausal symptoms on quality of life.
Change in Insomniaat the beginning of the study, 4 weeks and 8 weeks laterThe Women's Health Initiative Insomnia Rating Scale (WHIIRS) is a 5-item Likert-type scale used to evaluate insomnia symptoms, including sleep onset, sleep maintenance, early awakening, and sleep quality. Each item is scored between 0 and 4, with a total score ranging from 0 to 20. Higher scores indicate greater severity of insomnia

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026